Molecular You to Speak and Showcase its Platform at the Third Roundtable of Longevity Clinics

Novato, California – Molecular You, a leader in molecular medicine and preventive health, has been invited to deliver a keynote presentation and join an expert panel discussion on diagnostics at the Third Edition of the Roundtable of Longevity Clinics Summit, themed: The Future of Medicine – Eliminating Diseases of Aging. 

Molecular You will also showcase its platform at the event and offer free blood collections for longevity physicians to demonstrate its capabilities. The event will be held from December 6 – 8 at the Buck Institute for Research on Aging in Novato, California.

The Third Roundtable of Longevity Clinics will bring together experts from around the world to advance standards, training, and collaboration in the field of longevity. The Roundtable is regarded as a leading international forum for defining the future of clinical longevity practice.

“This event is an opportunity to highlight Molecular You’s commitment to helping clinicians move from reactive care to proactive, precision-guided interventions, particularly as we work toward expanding our platform’s capabilities, including our next-generation multi-omic assay which will more than triple the number of biomarkers we measure, including those associated with early-stage cancers and complex chronic diseases,” said Dr. Rob Fraser, PhD, Chief Scientific Officer, Co-Founder, and President of Molecular You.

Molecular You measures over 200 biomarkers with a single blood test to identify health risks at their root cause earlier, before symptoms present. The platform uses artificial intelligence (AI) to conduct in-depth analysis and provides a comprehensive overview of an individual’s overall health, along with personalized lifestyle recommendations to reduce disease risk.

In a documented case, the platform has already detected stage 1 pancreatic cancer in a symptom-free 60-year-old woman, enabling an early diagnosis that led to a life-saving intervention.

Key Activities at the Event:

Platform Demonstration: 

• Qualified longevity physicians can receive a complimentary blood draw to try Molecular You first-hand on Monday, December 8, during conference hours. (Limited availability; first-come, first-served.)
• Attendees can see a demonstration of the Molecular You platform and speak directly with the team throughout the event. 

Keynote Presentation: Translating Biomarker Insights into Pre-Diagnostic Longevity Practice

• Speaker: Dr. Rob Fraser, PhD, President, Co-Founder & Chief Scientific Officer, Molecular You
• Topic: The presentation will explore the rapidly evolving field of multi-omic medicine, focusing on how clinicians can leverage next-generation diagnostics to detect early disease signatures and drive personalized, preventive care. How multi-omic profiling and AI-driven analytics are enabling longevity clinics to transition from reactive to proactive care, shifting the focus from symptom management to disease anticipation and prevention.
• When: Sunday, December 7, from 3:30 PM – 3:50 PM

Panel Discussion: Measuring Longevity – Next-Gen Diagnostics & Biomarkers

• Speakers: Dr. Rob Fraser will join industry peers from TruDiagnostic, LifeMetrics, Caristo,  Medipredict, Glycan Age, and Neghabat Health LLC.
• The panel will explore emerging biomarker technologies, multi-omic data, and practical frameworks for integrating next-generation diagnostics into longevity-focused clinical workflows.
• When: Sunday, December 7, 1:45 – 2:50 PM

To view the full agenda, visit: https://longevity-roundtable.com/#agenda

-##-

About Molecular You
Molecular You measures over 200 biomarkers with a single blood test using advanced proteomics and metabolomics to identify health risks at their root cause. Its AI-powered platform delivers personalized assessments and insights, along with actionable recommendations for over 25 health areas, to support longevity, chronic disease management, and early disease prevention. Both individuals and clinical practices across the United States and Canada are increasingly leveraging Molecular You to maximize personal and patient health outcomes through predictive, preventive, and precision medicine. Learn more: https://www.molecularyou.com/